Delivery Order SPE2DB20D2014-SPE2DB25FC55F
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,086.48 to supply Janumet XR 100-1,000 mg tablets (90-count) with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under a larger contract vehicle. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at approximately $61.2K to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This contract, which was competitively awarded with no set-aside designation, became effective on July 24, 2025, with an ultimate completion date of July 25, 2025. The firm fixed-price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 100-1,000 mg tablets (30-count) valued at $1,002.54. The contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $1,924.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180 tablets of Janumet XR 50-1,000 mg to be delivered to a location in Conshohocken, Pennsylvania by June 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract from its Conshohocken facility. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to supply the...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,608.77 to supply 90 tablets of JANUMET XR 100-1,000 MG per unit. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all products delivered by December 19, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified. As a leading...
- The Defense Logistics Agency awarded a $5,318 delivery order to Amerisourcebergen Drug Corporation to supply 180 packages of Janumet XR 50-1,000 mg tablets. Amerisourcebergen will deliver the diabetes medication to a location in Conshohocken, Pennsylvania by July 24, 2023 under a firm fixed price contract. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen routinely supports the DLA's mission to provide worldwide logistics support to the Department of Defense and...
- The Defense Logistics Agency awarded a $9,327.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg, with an ultimate completion date of July 22, 2025. This non-set-aside award was issued on July 21, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,218.34 to Amerisourcebergen Drug Corporation for the supply of 4561772930 Janumet XR 50-1000 mg tablets, 180 count. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 11, 2023 under the terms of the order. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this order for diabetes medication...
- The Defense Logistics Agency Troop Support Medical awarded a $12,533.93 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 180 units of Janumet XR 50-1,000 mg tablets. The firm fixed price contract calls for delivery to a location in Conshohocken, Pennsylvania within a two-day period concluding on August 16, 2023. Amerisourcebergen Corporation will perform as the prime contractor for this requirement to support the Defense Logistics Agency's medical supply chain...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC55FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,866.22 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As a primary vendor under the DLA Medical Supply Chain, the company supplies a broad portfolio of pharmaceutical products spanning multiple therapeutic domains. Janumet XR is a combination diabetes medication used in military and federal healthcare settings to manage type 2 diabetes, reflecting AmerisourceBergen's role in supporting military medical readiness and veteran healthcare needs through its extensive network of competitively awarded federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 7/24/25 |